1. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. Issue 11 (November 2021) Authors: Bancroft, Elizabeth K; Page, Elizabeth C; Brook, Mark N; Thomas, Sarah; Taylor, Natalie; Pope, Jennifer; McHugh, Jana; Jones, Ann-Britt; Karlsson, Questa; Merson, Susan; Ong, Kai Ren; Hoffman, Jonathan; Huber, Camilla; Maehle, Lovise; Grindedal, Eli Marie; Stormorken, Astrid; Evans, D Gareth; Rot... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial. Issue 3 (March 2022) Authors: Fennell, Dean A; King, Amy; Mohammed, Seid; Greystoke, Alastair; Anthony, Sarah; Poile, Charlotte; Nusrat, Nada; Scotland, Molly; Bhundia, Vina; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Bajaj, Amrita; Richards, Cathy; Wells-Jord... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. (June 2022) Authors: Fennell, Dean A.; Porter, Catharine; Lester, Jason; Danson, Sarah; Taylor, Paul; Sheaff, Michael; Rudd, Robin M; Gaba, Aarti; Busacca, Sara; Nixon, Lisette; Gardner, Georgina; Darlison, Liz; Poile, Charlotte; Richards, Cathy; Jordan, Peter-Wells; Griffiths, Gareth; Casbard, Angela Journal: EClinicalMedicine Issue: Volume 48(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS). (April 2023) Authors: Fennell, Dean; Griffiths, Daniel; Eminton, Zina; Morgan-Fox, Abigail; Hill, Kayleigh; Nearchou, Theodora; Johnson, Lucy; Harding, Stephanie; Poile, Charlotte; Bzura, Aleksandra; Spicer, Jake; Nye, Mavis; Cave, Judith; Danson, Sarah; Toy, Elizabeth; Jain, Pooja; Steele, Nicola; Shaw, Paul; Taylor,... Journal: Lung cancer Issue: Volume 178(2023)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. Issue 11 (November 2021) Authors: Fennell, Dean A; Ewings, Sean; Ottensmeier, Christian; Califano, Raffaele; Hanna, Gerard G; Hill, Kayleigh; Danson, Sarah; Steele, Nicola; Nye, Mavis; Johnson, Lucy; Lord, Joanne; Middleton, Calley; Szlosarek, Peter; Chan, Sam; Gaba, Aarti; Darlison, Liz; Wells-Jordan, Peter; Richards, Cathy; Poi... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial. Issue 6 (June 2021) Authors: Fennell, Dean A; King, Amy; Mohammed, Seid; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Nicholson, Adrian; Richards, Cathy; Wells-Jordan, Peter; Murphy, Gavin James; Thomas, Anne; Fennell, Dean Anthony; King, Amy; Mohammed, Seid; B... Journal: Lancet Issue: Volume 9:Issue 6(2021) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗